메뉴 건너뛰기




Volumn 5, Issue 1, 2003, Pages 76-94

The entrepreneurial environment for biotech start-ups in Germany and Japan

Author keywords

Bioentrepreneurship; Bioventures; Germany; IPO; Japan; Technology transfer; Venture capital

Indexed keywords

ECONOMIC AND SOCIAL EFFECTS; PERSONNEL; PLANT STARTUP;

EID: 0041977038     PISSN: 09636048     EISSN: None     Source Type: Journal    
DOI: 10.1504/IJBT.2003.002115     Document Type: Review
Times cited : (16)

References (22)
  • 1
    • 0041787711 scopus 로고    scopus 로고
    • note
    • More precisely, biotechnology is not an industry per se it is rather a set of technologies. However, in this paper we define the boundary to other industries by the entirety of organisations that use mainly biotechnologies for undertaking R&D and developing products.
  • 2
    • 0035062034 scopus 로고    scopus 로고
    • National institutional frameworks and the hybridization of entrepreneurial business models: The German and UK biotechnology sectors
    • Casper, S. (2001) 'National institutional frameworks and the hybridization of entrepreneurial business models: the German and UK biotechnology sectors', Industry and Innovation, Vol. 8, No. 1, pp.5-30.
    • (2001) Industry and Innovation , vol.8 , Issue.1 , pp. 5-30
    • Casper, S.1
  • 4
    • 0005768452 scopus 로고    scopus 로고
    • Industrial structure and the dynamics of knowledge generation in biotechnology
    • L. Senker and R. van Vliet (Eds.), Cheltenham, UK
    • Saviotti, P.P. (1998) 'Industrial structure and the dynamics of knowledge generation in biotechnology', in L. Senker and R. van Vliet (Eds.) Biotechnology and Competitive Advantage, Cheltenham, UK, pp.19-43.
    • (1998) Biotechnology and Competitive Advantage , pp. 19-43
    • Saviotti, P.P.1
  • 5
    • 84982071448 scopus 로고
    • Strategic alliances between large and small research intensive organizations: Experiences in the biotechnology
    • Forrest, J.E. and Martin, M.J.C. (1992) 'Strategic alliances between large and small research intensive organizations: experiences in the biotechnology', R&D Management, Vol. 22, No. 1, pp.41-53.
    • (1992) R&D Management , vol.22 , Issue.1 , pp. 41-53
    • Forrest, J.E.1    Martin, M.J.C.2
  • 8
    • 0042288777 scopus 로고    scopus 로고
    • note
    • Biotech companies "[...] are defined as companies that use modern biological techniques to develop products or services to serve the needs of human health-care, agricultural productivity, food processing, renewable resources or environmental affairs. Medical device, seed companies, and large pharmaceutical companies ('Big Pharma') are excluded [...]", see [7].
  • 9
    • 0041287122 scopus 로고    scopus 로고
    • BMBF - Bundesministerium für Bildung und Forschung (2001) www.bmbf.de
    • (2001)
  • 10
    • 0042789875 scopus 로고    scopus 로고
    • Wachstum und konsolidierung der Biotech-Branche in Deutschland
    • C. Herstatt and C. Müller (Eds.), Schaeffer-Poeschel, Stuttgart
    • Mietzsch, A. (2002) 'Wachstum und konsolidierung der Biotech-Branche in Deutschland', in C. Herstatt and C. Müller (Eds.) Management-Handbuch Biotechnologie, Schaeffer-Poeschel, Stuttgart.
    • (2002) Management-Handbuch Biotechnologie
    • Mietzsch, A.1
  • 11
    • 0029128834 scopus 로고
    • Success rates for new drugs entering clinical testing in the United States
    • DiMasi, J.A. (1995) 'Success rates for new drugs entering clinical testing in the United States', in Clinical Pharmacology & Therapeutics, Vol. 58, No. 1, pp.1-14.
    • (1995) Clinical Pharmacology & Therapeutics , vol.58 , Issue.1 , pp. 1-14
    • DiMasi, J.A.1
  • 13
    • 0003734814 scopus 로고    scopus 로고
    • Washington, USA
    • Pharmaceutical Research and Manufacturers (2000) Pharmaceutical Industry Profile 2000, Washington, USA (www.phrma.org).
    • (2000) Pharmaceutical Industry Profile 2000
  • 14
    • 0042789879 scopus 로고    scopus 로고
    • note
    • As of July 2001, at 25 German universities, chairs for entrepreneurship have been established or will be established in the near future.
  • 16
    • 0009477617 scopus 로고    scopus 로고
    • Personal management in Biotech-Unternehmen
    • C. Herstatt and C. Müller (Eds.), Schäffer-Poeschel, Stuttgart
    • Staudt, E., Kottman, M. and Sieger, C. (2002) 'Personal management in Biotech-Unternehmen', in C. Herstatt and C. Müller (Eds.) Management-Handbuch Biotechnologie, Schäffer-Poeschel, Stuttgart.
    • (2002) Management-Handbuch Biotechnologie
    • Staudt, E.1    Kottman, M.2    Sieger, C.3
  • 17
    • 0042288776 scopus 로고    scopus 로고
    • IMS Health, www.imshealth.com.
  • 19
    • 0041287115 scopus 로고    scopus 로고
    • (Japan Bioindustry Organization), Tokyo, 10 August
    • Personal Communication (2001) Dr. Chigira (Japan Bioindustry Organization), Tokyo, 10 August.
    • (2001)
    • Chigira1
  • 20
    • 0042288772 scopus 로고    scopus 로고
    • Biotechnology start-up enterprises in Japan: On transferability from Japanese management to start-up management
    • Leveraging Research and Technology, Wellington, New Zealand
    • Fujiwara, T. (2001) 'Biotechnology start-up enterprises in Japan: on transferability from Japanese management to start-up management', Proceedings of the R&D Management Conference 2001, Leveraging Research and Technology, Wellington, New Zealand.
    • (2001) Proceedings of the R&D Management Conference 2001
    • Fujiwara, T.1
  • 21
    • 0041787708 scopus 로고    scopus 로고
    • Ministry of Economy, Trade and Industry, METI, www.meti.go.jp.
  • 22
    • 0041787707 scopus 로고    scopus 로고
    • note
    • Note that the definition of biotechnology related companies differs significantly from the Ernst & Young term of Entrepreneurial Life-Sciences Companies. The Japan Bioindustry Association defines biotechnology companies as companies which conduct research in biotechnology (modern as well as old biotechnology) and which were established after 1980.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.